Blog

Posted on

Last day!

The production schedule read, “Final Materials to Printer – July 2,” and I’m gonna get those final materials to the printer by July 2! Just a couple hundred words more about Pfizer and a brief writeup about Abbott Laboratories, and this year’s Top 20 Pharma / Top 10 Biopharma ish will be finished!

So don’t expect any more posts today.

In other news, it looks like the constant dreariness and rainfall of June has had at least one positive effect: the deer have had enough to eat in the woods and have (mostly) left my tigerlilies alone!

Posted on

What It Is: 6/29/09

What I’m reading: Plutarch’s life of Aemilius Paulus, and a little of The Hunter, a Richard Stark (Donald Westlake) book. But I’m in the home-stretch for my Top Companies ish, so I’ve just been reading a lot of SEC filings, analyst reports and various pharma-bloggers.

What I’m listening to: A whole ton of Michael Jackson music.

What I’m watching: A whole ton of Michael Jackson videos. And the Yankees beating up the Mets.

What I’m drinking: Blue Point Blueberry Ale.

What Rufus is up to: Going on his first greyhound hike in about 8 weeks and having a great time catching up with his pals.

Where I’m going: On a weeklong vacation (to nowhere) once this issue is done.

What I’m happy about: The Top Companies issue is just about done. It’s gonna be a hard couple of days to finish it, but I can visualize the end of it.

What I’m sad about: That Dad’s gout has stuck around, making his life pretty miserable.

What I’m worried about: Getting in trouble because I failed to mail back my jury duty notice. See, I misread the form and thought I was only supposed to mail it in if I was trying to get a deferral. Oops. On the upside, my juror number is above the cut-off point, so I won’t have to go serve on Tuesday.

What I’m pondering: Whether Ron Rosenbaum knows anyone under the age of 40.

Posted on

Worse than Ezra

Ahoy, ahoy, dear readers! I’m way too busy reading pharmaco financials and analyst reports to spend much time blogging. Updates will be pretty light until July 4thish. (Of course there’ll be an Unrequired Reading this Friday! Don’t be silly!)

Just so you get your fix, the 0-fer of the week is . . . Ezra Pound!

Now I gotta get back to work. Later!

Posted on

“Anything but . . . work in a paper box factory!”

A “Key Figure” from sanofi-aventis’ annual report:

boxy

The title of this post is from one of my favorite Woody Allen movies. Relax: I don’t expect any of you to get that one.

(UPDATE: Summamabitch! sanofi got revenge on me! I was about 80% of the way through its profile, for an issue that goes to press early next week, when I got a pharma e-newsletter with a link to the following item:

Sanofi-Aventis Plans Job Cuts

M2 Europharma – Jun. 22, 2009

22 June 2009 -French pharmaceutical group Sanofi-Aventis (EPA: SAN) may further cut jobs after the 927 lay-offs in 2008, business daily Les Echos reported on Monday (22 June), quoting trade union sources.

Sanofi-Aventis management is expected to announce the plans for major restructuring at an extraordinary works council next week. Employees are particularly concerned over positions in the research divisions.

The drug maker has been affected by the launch of generic versions of some of its key medicines. Within the coming months the generic version of its anti-cancer drug Eloxatin should …

Of course, the full announcement’s only going to come after the company’s profile is off at the printer! Grr!)

Posted on

Lollygagging around

Oh, sure! You can take it easy, while I’m slaving away over these darned pharma-profiles! You’re lucky you’re so cute!